Log in to save to my catalogue

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vacc...

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vacc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68019758

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094)

About this item

Full title

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094)

Publisher

Oxford: Elsevier Ltd

Journal title

Vaccine, 2005-07, Vol.23 (34), p.4292-4301

Language

English

Formats

Publication information

Publisher

Oxford: Elsevier Ltd

More information

Scope and Contents

Contents

This open single-arm study evaluated whether the administration of an HIV-recombinant canarypox vaccine (vCP1433) in highly active antiretroviral therapy (HAART)-treated patients chronically infected with HIV was safe, immunogenic and associated with prolongation of treatment discontinuation: 48 patients received four monthly vCP1433 injections and...

Alternative Titles

Full title

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68019758

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68019758

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2005.04.013

How to access this item